Compare AXON & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXON | TEVA |
|---|---|---|
| Founded | 1993 | 1901 |
| Country | United States | Israel |
| Employees | N/A | 32842 |
| Industry | Ordnance And Accessories | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.1B | 37.1B |
| IPO Year | 2001 | N/A |
| Metric | AXON | TEVA |
|---|---|---|
| Price | $508.49 | $32.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 8 |
| Target Price | ★ $758.80 | $38.63 |
| AVG Volume (30 Days) | 1.1M | ★ 5.1M |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.05 | N/A |
| Revenue | ★ $2,779,536,000.00 | N/A |
| Revenue This Year | $31.50 | N/A |
| Revenue Next Year | $28.95 | $2.97 |
| P/E Ratio | $263.15 | ★ $28.19 |
| Revenue Growth | ★ 33.47 | N/A |
| 52 Week Low | $339.01 | $14.99 |
| 52 Week High | $885.92 | $37.35 |
| Indicator | AXON | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 42.35 |
| Support Level | $496.58 | $30.59 |
| Resistance Level | $515.80 | $32.40 |
| Average True Range (ATR) | 33.84 | 0.89 |
| MACD | -8.56 | -0.19 |
| Stochastic Oscillator | 12.77 | 18.14 |
Axon Enterprise Inc is building a public safety operating system by integrating a suite of hardware devices and cloud software solutions. The company's suite includes cloud-hosted digital evidence management solutions, TASER energy devices, drones and robotic security, and training solutions. Its operation comprises of two operating segments, Software and Services, and Connected Devices. The company generates the majority of its revenue from the Connected Devices segment, which is engaged in developing, manufacturing, and selling fully integrated hardware solutions such as conducted energy devices sold under the TASER brand, body cameras, fixed and in-car cameras, drone and counter-drone technologies, and a broad ecosystem of accessories, extended warranties and related hardware products.
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.